Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 1/2016

20-06-2015

Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity

Auteurs: Sevim Bavbek, Seçil Kepil Özdemir, Beyza Doğanay Erdoğan, Işıl Karaboğa, Suna Büyüköztürk, Aslı Gelincik, İnsu Yılmaz, Özlem Göksel, Adile Berna Dursun, Gül Karakaya, Ali Fuat Kalyoncu, Ferhan Özşeker, Gülden Paşaoğlu Karakış, Ferda Öner Erkekol, Gözde Köycü, Metin Keren, Ilaria Baiardini, Antonino Romano

Gepubliceerd in: Quality of Life Research | Uitgave 1/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The first disease-specific quality-of-life questionnaire in patients with drug hypersensitivity, Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q), was developed and validated recently. The aim of this study was to assess validity, reliability and responsiveness to interventions of the Turkish version of the DrHy-Q.

Methods

The Turkish version of the DrHy-Q was administered to prospectively enrolled 736 patients with drug hypersensitivity from ten allergy units. To assess validity, all patients completed the validated Turkish version of Psychological General Well-Being Index (PGWBI). For test–retest reliability, 182 patients completed the DrHy-Q 1 week after the first questionnaire administration without any intervention. Responsiveness was assessed on 97 patients who had a DrHy-Q recorded at a follow-up visit after the intervention.

Results

The internal consistency and test–retest reliability of the scale were adequate (Cronbach’s alpha = 0.934, intra-class correlation coefficient = 0.783). The DrHy-Q scores showed weak negative correlations with the PGWBI total and domain scores (r = − 0.378 to −0.254, p < 0.001). DrHy-Q was able to discriminate the patients with one drug hypersensitivity reaction from the patients with two and above two reactions (p = 0.012 and p < 0.001, respectively), and the patients who experienced a respiratory reaction from the patients who did not (p = 0.018). However, it did not discriminate the patients with comorbid disease including psychiatric comorbidity (p > 0.05). The baseline DrHy-Q scores were significantly higher than the post-intervention scores (p = 0.008).

Conclusion

The Turkish version of DrHy-Q is reliable and valid for evaluating quality of life in patients with drug hypersensitivity, and it appeared responsive to interventions.
vorige artikel Cultural adaptation and validation of the Chinese version of the Fatigue Severity Scale in patients with major depressive disorder and nondepressive people
volgende artikel Normative data and psychometric properties of the Connor–Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong Kong
Literatuur
1.
Baiardini, I., Pasquali, M., Giardini, A., Specchia, C., Passalacqua, G., Venturi, S., et al. (2003). Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma. Allergy, 38, 289–294.CrossRef
2.
Gomes, E., Cardoso, M. F., Praça, F., Gomes, L., Mariño, E., & Demoly, P. (2004). Self-reported drug allergy in a general Portuguese population. Clinical and Experimental Allergy, 34, 1597–1601.PubMedCrossRef
3.
Demoly, P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., et al. (2014). International consensus on drug allergy. Allergy, 69, 420–437.PubMedCrossRef
4.
Bavbek, S., Erkekol, F. Ö., Celik, G. E., Gönüllü, I., & Misirligil, Z. (2011). Self-reported prevalence of hypersensitivity reactions against drugs among medical students: Does awareness cause any difference? Pharmacoepidemiology and Drug Safety, 20(2), 154–161.PubMedCrossRef
5.
Bavbek, S., Celik, E. G., Aydın, O., Oner Erkekol, F., Kursun, N., Mungan, D., et al. (2012). Prevalence of hypersensitivity reactions against drugs among adult population in Turkey: A self reported survey. Journal of Public Health, 20, 585–592.CrossRef
6.
Bavbek, S., Pasaoğlu, G., Canat, S., Sağduyu, G., & Mısırlığıl, Z. (2006). Allergy to drugs: How important for psychological epidemiology? International Journal on Psychiatry in Clinical Practice, 10(1), 64–68.CrossRef
7.
Baiardini, I., Braido, F., Fassio, O., Calia, R., Canonica, G. W., Romano, A., & DrHy-Q PROs Research Italian Group. (2011). Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Annals of Allergy, Asthma & Immunology, 106, 330–335.CrossRef
8.
Testa, M. A., & Simonson, D. C. (1996). Assessment of quality-of-life outcomes. New England Journal of Medicine, 334, 835–840.PubMedCrossRef
9.
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef
10.
Streiner, D. L., & Norman, G. R. (1995). Health measurement scales. A practical guide to their development and use (2nd ed., pp. 104–126). New York: Oxford Medical Publications.
11.
Fleiss, J. L., Levin, B., & Paik, M. C. (2003). Statistical methods for rates and proportions. Hoboken, NJ: Wiley.CrossRef
12.
Ay, S., Koldaş Doğan, Ş., Evcik, D., Gök, H., Tur, B. S., & Gökmen, D. (2010). Reliability and validity of psychological general well-being index in Turkish population. Turkish Journal of Physical Medicine and Rehabilitation, 56, 161–169.
13.
Dupuy, H. (1984). The psychological general well-being (PGWB) index. In N. K. Wenger, M. E. Mattson, C. D. Furberg, & J. Elinson (Eds.), Assessment of quality of life in clinical trials of cardiovascular therapies (pp. 170–183). Greenwich, CT: Le Jacq Publishing Inc.
14.
Ertam, I., Kitapcioglu, G., Aksu, K., et al. (2009). Quality of life and its relation with disease severity in Behçet’s disease. Clinical and Experimental Rheumatology, 27, S18–S22.PubMed
15.
Pallant, J. F., Kenan, A. M., Misajon, R., Conaghan, P. G., & Tennant, A. (2009). Measuring the impact and distress of osteoarthritis from the patients’ perspective. Health and Quality of Life Outcomes, 29(7), 37.CrossRef
16.
Pai, A. L., Mullins, L. L., Drotar, D., Burant, C., Wagner, J., & Chaney, J. M. (2007). Exploratory and confirmatory factor analysis of the child uncertainty in illness scale among children with chronic illness. Journal of Pediatric Psychology, 32, 288–296.PubMedCrossRef
17.
Copay, A. G., Subach, B. R., Glassman, S. D., Polly, D. W, Jr, & Schuler, T. C. (2007). Understanding the minimum clinically important difference: A review of concepts and methods. The Spine Journal, 7, 541–546.PubMedCrossRef
18.
Cohen, J. (1977). Statistical power: Analysis for behavioral sciences. New York: Academic Press.
19.
Muthen, L. K., & Muthen, B. O. (1998–2007). Mplus user’s guide, 5th edn. Los Angeles, CA: Muthen and Muthen.
20.
21.
Baiardini, I., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., et al. (2010). Global allergy and asthma European network. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: A GA(2)LEN task force position paper. Allergy, 65(3), 290–295.PubMedCrossRef
22.
Smith, K. W., Avis, N. E., & Assmann, S. F. (1999). Distinguishing between quality of life and health status in quality of life research: A metaanalysis. Quality of Life Research, 8, 447–459.PubMedCrossRef
23.
Simons, F. E., Ardusso, L. R., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., et al. (2011). World Allergy Organization anaphylaxis guidelines: Summary. Journal of Allergy and Clinical Immunology, 127, 587–593.PubMedCrossRef
Metagegevens
Titel
Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity
Auteurs
Sevim Bavbek
Seçil Kepil Özdemir
Beyza Doğanay Erdoğan
Işıl Karaboğa
Suna Büyüköztürk
Aslı Gelincik
İnsu Yılmaz
Özlem Göksel
Adile Berna Dursun
Gül Karakaya
Ali Fuat Kalyoncu
Ferhan Özşeker
Gülden Paşaoğlu Karakış
Ferda Öner Erkekol
Gözde Köycü
Metin Keren
Ilaria Baiardini
Antonino Romano
Publicatiedatum
20-06-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1051-2

Andere artikelen Uitgave 1/2016

Quality of Life Research 1/2016 Naar de uitgave

Review Paper

Ostomy-related problems and their impact on quality of life of colorectal cancer ostomates: a systematic review

OriginalPaper

Reliability and validity of the Cancer Therapy Satisfaction Questionnaire in lung cancer

OriginalPaper

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers)

OriginalPaper

Development of an item bank for computerized adaptive test (CAT) measurement of pain

Brief Communication

Social support in older people: lessons from a developing country

OriginalPaper

Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method